Literature DB >> 9120260

Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.

N R Chu1, M A DeBenedette, B J Stiernholm, B H Barber, T H Watts.   

Abstract

The costimulatory receptor CD28 is important in the development of both Th1 and Th2 responses. To further assess the requirement for CD28 in the development of Th1 and Th2 responses, we analyzed the ability of T cells from wild-type or CD28- mice to secrete cytokines in MLRs with B lymphomas. We find that in the absence of added IL-12, B lymphomas expressing the alternate costimulatory ligand 4-1BBL can support the production of IL-2 and IL-4 but little detectable IFN-gamma by allogeneic CD28+ and CD28- T cells. IL-4 production by CD28+ or CD28- T cells responding to B7(low) B lymphomas was abrogated by blocking 4-1BB ligand-4-1BB interaction. When APC express high levels of B7 family molecules as well as 4-1BBL, soluble 4-1BB inhibits IL-4 production by CD28- but not by CD28+ cells. Addition of IL-12 to the CD28- MLRs results in increased production of IFN-gamma and decreased amounts of IL-2 and IL-4. Thus, both Th1 and Th2 responses can develop in the complete absence of a signal through the CD28 molecule. CD28+ and CD28- T cells differed, however, with respect to the effect of IL-12 on IL-4 production. IL-12 severely curtailed the amount of IL-4 produced in the CD28- T cell cultures but had a less profound effect on the level of IL-4 produced in the CD28+ cultures, suggesting that a strong signal through the CD28 molecule prevents down-regulation of IL-4 production by IL-12.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes.

Authors:  Kwang-Mi Kim; Ho Won Kim; Jae-Ouk Kim; Kyoung-Min Baek; Joong Gon Kim; Chang-Yuil Kang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 2.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  The pharmacology of second-generation chimeric antigen receptors.

Authors:  Sjoukje J C van der Stegen; Mohamad Hamieh; Michel Sadelain
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

4.  Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

Authors:  G A Arreaza; M J Cameron; A Jaramillo; B M Gill; D Hardy; K B Laupland; M J Rapoport; P Zucker; S Chakrabarti; S W Chensue; H Y Qin; B Singh; T L Delovitch
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance.

Authors:  Y X Zhao; G Lajoie; H Zhang; B Chiu; U Payne; R D Inman
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor.

Authors:  Hajime Nishimoto; Seung-Woo Lee; Hong Hong; Karen G Potter; Mari Maeda-Yamamoto; Tatsuya Kinoshita; Yuko Kawakami; Robert S Mittler; Byoung S Kwon; Carl F Ware; Michael Croft; Toshiaki Kawakami
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

Review 7.  Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity.

Authors:  Takanori So; Seung-Woo Lee; Michael Croft
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

8.  4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae.

Authors:  Zheng-Qi Wu; Abdul Q Khan; Yi Shen; Karen M Wolcott; Wojciech Dawicki; Tania H Watts; Robert S Mittler; Clifford M Snapper
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.

Authors:  Yun-Le Wan; Shu-Sen Zheng; Zhi-Cheng Zhao; Min-Wei Li; Chang-Ku Jia; Hao Zhang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

10.  Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.

Authors:  Jacob Bukczynski; Tao Wen; Kim Ellefsen; Jack Gauldie; Tania H Watts
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.